• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

drug development

  • A pill-a-day HIV treatment offers significant advantages over current regiments
    June 1, 2018

    A pill-a-day HIV treatment offers significant advantages over current regiments

    scientificinquirer
  • Some bacteria have a self-destruct button. It’s hitting it that’s the problem.
    April 30, 2018

    Some bacteria have a self-destruct button. It’s hitting it that’s the problem.

    scientificinquirer
  • Conversations with Timothy Wencewicz: Developing new antibiotics during the age of resistance
    April 30, 2018

    Conversations with Timothy Wencewicz: Developing new antibiotics during the age of resistance

    scientificinquirer
  • Scientists are closing in on an atherosclerosis vaccine
    April 17, 2018

    Scientists are closing in on an atherosclerosis vaccine

    scientificinquirer
  • Soil bacteria provide source of a new class of antibiotic
    April 10, 2018

    Soil bacteria provide source of a new class of antibiotic

    scientificinquirer
  • Neuraminidase targeting flu vaccines may offer broader protection
    April 10, 2018

    Neuraminidase targeting flu vaccines may offer broader protection

    scientificinquirer
  • New class of antibiotics are swift MRSA killers
    April 2, 2018

    New class of antibiotics are swift MRSA killers

    scientificinquirer
  • One day, doctors may test a drug’s efficacy on chips before using on humans
    February 20, 2018

    One day, doctors may test a drug’s efficacy on chips before using on humans

    scientificinquirer
  • Is this the answer to the scaling up problem facing HIV vaccines?
    February 8, 2018

    Is this the answer to the scaling up problem facing HIV vaccines?

    scientificinquirer
  • Scientists chip away at a sexual superbug’s resistance armor
    February 7, 2018

    Scientists chip away at a sexual superbug’s resistance armor

    scientificinquirer
Previous Page
1 … 50 51 52 53 54 55
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
 

Loading Comments...